1.Drummond, MF, Sculpher, MJ, Torrance, G, O'Brien, J, Stoddart, GL. Methods for the economic evaluation of health care programmes. 3rd ed.Oxford University Press, 2005.
2.Drummond, MF, Schwartz, JS, Jönsson, B, Luce, BR, Neumann, PJ, Siebert, U, et al.Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care 2008;24:244–58.
3.Rennie, D, Luft, HS. Pharmacoeconomic analyses. JAMA 2000;283:2158–60.
4.Neumann, PJ, Stone, PW, Chapman, RH, Sandberg, EA, Bell, CM. The quality of reporting in published cost-utility analyses, 1976–1997. Ann Intern Med 2000;132:964.
5.Rosen, AB, Greenberg, D, Stone, PW, Olchanski, NV, Neumann, PJ. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Making 2005;25:424–8.
6.Turner, L, Shamseer, L, Altman, DG, Schulz, KF, Moher, D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev 2012;1:60.
7.Drummond, MF. A reappraisal of economic evaluation of pharmaceuticals. Science or marketing? Pharmacoeconomics 1998;14:1–9.
8.McGhan, WF, Al, M, Doshi, JA, Kamae, I, Marx, SE, Rindress, D. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force report. Value Health 2009;12:1086–99.
9.Task Force on Principles for Economic Analysis of Health Care Technology. Economic analysis of health care technology. A report on principles. Ann Intern Med 1995;123:61–70.
10.Drummond, MF, Jefferson, TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 1996;313:275–83.
11.Gold, MR. Cost-effectiveness in health and medicine. Oxford University Press, 1996.
12.Siegel, JE, Weinstein, MC, Russell, LB, Gold, MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276:1339–41.
13.Nuijten, MJ, Pronk, MH, Brorens, MJ, Hekster, YA, Lockefeer, JH, de Smet, PA, et al.Reporting format for economic evaluation: Part II: Focus on modelling studies. Pharmacoeconomics 1998;14:259–68.
14.Vintzileos, AM, Beazoglou, T. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics. Am J Obstet Gynecol 2004;191:1070–6.
15.Drummond, M, Manca, A, Sculpher, M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 2005;21:165–71.
16.Ramsey, S, Willke, R, Briggs, A, Brown, R, Buxton, M, Chawla, A, et al.Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. Value Health 2005;8:521–33.
17.Goetghebeur, MM, Wagner, M, Khoury, H, Levitt, RJ, Erickson, LJ, Rindress, D. Evidence and value: impact on decisionmaking—the EVIDEM framework and potential applications. BMC Health Serv Rev 2008;8:270.
18.Davis, JC, Robertson, MC, Comans, T, Scuffham, PA. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int 2010;22:2449–59.
19.Petrou, S, Gray, A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ 2011;342:d1766.
20.Petrou, S, Gray, A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ 2011;342:d1548.
21.Husereau, D, Drummond, M, Petrou, S, Carswell, C, Moher, D, Greenberg, D, et al.Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—explanation and elaboration: a report of the ISPOR Health Economic Evaluations Publication Guidelines Task Force. Value in Health (forthcoming).
22.Moher, D, Schulz, KF, Simera, I, Altman, DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7:e1000217.
23.Moher, D, Weeks, L, Ocampo, M, et al. Describing reporting guidelines for health research: a systematic review. J Clin Epi 2011;64:718–42.
24.Campbell, SM, Hann, M, Roland, MO, Quayle, JA, Shekelle, PG. The effect of panel membership and feedback on ratings in a two-round Delphi survey: results of a randomized controlled trial. Med Care 1999;37:964–8.